BioSymetrics CEO and Key Executive Team

• Anthony Iacovone

  Co-Founder and Chief Executive Officer
• Gabriel Musso

  Co-Founder and Chief Scientific Officer
• Matthew Fusco

  Board Director
• Stacie Calad-Thomson

  Chief Strategy Officer and Head of Drug Discovery
• Victoria Catterson

  Vice President of Data Science Research
• Dave Kokel

  VP of Discovery Biology
• Mikalai Malinouski

  Senior Director of Portfolio Development and Early Commercial Strategy
• Michele Arena

  Director of Project Management
• Emilie TE Gross

  Director of Business Development

Source: biosymetrics.com